Beglan | FDA Orange Book | Approved Drug Product List | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Clinical Trials
- Clinical Trials
Drugs in Dev.
News
Blog
Market Place
Login

Beglan
FDA Orange Book

PharmaCompass Sponsored Ads

Contact Supplier

Vamsi labs Salmeterol Xinafoate

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

pharmacompass-2-m-2026-04-20

Beglan

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 21 USDMF, 12 CEP/COS, 1 JDMF, 9 EU WC, 13 NDC API, 28 Listed Suppliers

41 API Suppliers
21 USDMF
12 CEP/COS
1 JDMF
9 EU WC
13 NDC API
28 Listed Suppliers

DEVELOPMENTS

34 Drugs in Development

34 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

780 FDF Dossiers, 25 FDA Orange Book, 637 Europe, 12 Canada, 50 Australia, 31 South Africa, 25 Listed Dossiers

780 FDF Dossiers
25 FDA Orange Book
637 Europe
12 Canada
50 Australia
31 South Africa
25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH, AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH

POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH
POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH
POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH
POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH
POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH
POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH
AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH
AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH
AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH

RELATED EXCIPIENT COMPANIES

2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 BASF, 2 DFE Pharma, 12 Kerry, 2 Microlex e.U, 1 Pluviaendo, 1 Roquette, 1 Sigachi Industries

2 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
2 BASF
2 DFE Pharma
12 Kerry
2 Microlex e.U
1 Pluviaendo
1 Roquette
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

10 Fillers, Diluents & Binders, 9 Granulation, 7 Direct Compression, 3 Co-Processed Excipients, 2 Chewable & Orodispersible Aids, 1 Coating Systems & Additives, 1 Controlled & Modified Release, 1 Parenteral

10 Fillers, Diluents & Binders
9 Granulation
7 Direct Compression
3 Co-Processed Excipients
2 Chewable & Orodispersible Aids
1 Coating Systems & Additives
1 Controlled & Modified Release
1 Parenteral

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 82 News #PharmaBuzz

3 Data Compilation #PharmaFlow
82 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions, 78 Regulatory FDF Prices

10 US Medicaid Prescriptions
78 Regulatory FDF Prices

MARKET PLACE

4 APIs, 2 FDF Dossiers

4 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

58 US Patents, 71 Health Canada Patents

58 US Patents
71 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 USP, 3 Others

3 EDQM
4 USP
3 Others

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

26 All

01 6GLAXO GRP LTD

02 2GLAXOSMITHKLINE

03 1HANGZHOU BINJIANG

04 1HIBROW HLTHCARE

05 3HIKMA

06 3MYLAN

07 2RESPIRENT PHARMS

08 5TEVA PHARM

09 3TEVA PHARMS USA

filter Dosage Reset all filters

26 All

01 4AEROSOL, METERED;INHALATION

02 20POWDER;INHALATION

03 1TABLET, EXTENDED RELEASE;ORAL

04 1TABLET;ORAL

filter Regulatory Info Reset all filters

26 All

01 6DISCN

02 20RX

filter Brand Name Reset all filters

26 All

01 1ADVAIR DISKUS 100/50

02 1ADVAIR DISKUS 250/50

03 1ADVAIR DISKUS 500/50

04 3ADVAIR HFA

05 3AIRDUO DIGIHALER

06 2AIRDUO RESPICLICK

07 8FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE

08 1OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

09 1POTASSIUM CITRATE

10 2SEREVENT

11 3WIXELA INHUB

filter RLD Reset all filters

26 All

01 14No

02 12Yes

Inke Salmeterol Xinafoate

List of Suppliers

Product Main Page

01

GLAXOSMITHKLINE

PEGS Boston Summit

Not Confirmed

GLAXOSMITHKLINE

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code :

SALMETEROL XINAFOATE

Brand Name : SEREVENT

Dosage Form : AEROSOL, METERED;INHALATION

Dosage Strength : EQ 0.021MG BASE/INH

Approval Date : 1994-02-04

Application Number : 20236

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GLAXOSMITHKLINE

PEGS Boston Summit

Not Confirmed

GLAXOSMITHKLINE

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

SALMETEROL XINAFOATE

Brand Name : SEREVENT

Dosage Form : POWDER;INHALATION

Dosage Strength : EQ 0.05MG BASE/INH

Approval Date : 1997-09-19

Application Number : 20692

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GLAXO GRP LTD

PEGS Boston Summit

Not Confirmed

GLAXO GRP LTD

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Brand Name : ADVAIR DISKUS 100/50

Dosage Form : POWDER;INHALATION

Dosage Strength : 0.1MG/INH;EQ 0.05MG BASE/INH

Approval Date : 2000-08-24

Application Number : 21077

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GLAXO GRP LTD

PEGS Boston Summit

Not Confirmed

GLAXO GRP LTD

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Brand Name : ADVAIR DISKUS 250/50

Dosage Form : POWDER;INHALATION

Dosage Strength : 0.25MG/INH;EQ 0.05MG BASE/INH

Approval Date : 2000-08-24

Application Number : 21077

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GLAXO GRP LTD

PEGS Boston Summit

Not Confirmed

GLAXO GRP LTD

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Brand Name : ADVAIR DISKUS 500/50

Dosage Form : POWDER;INHALATION

Dosage Strength : 0.5MG/INH;EQ 0.05MG BASE/INH

Approval Date : 2000-08-24

Application Number : 21077

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

GLAXO GRP LTD

PEGS Boston Summit

Not Confirmed

GLAXO GRP LTD

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Brand Name : ADVAIR HFA

Dosage Form : AEROSOL, METERED;INHALATION

Dosage Strength : 0.045MG/INH;EQ 0.021MG BASE/INH

Approval Date : 2006-06-08

Application Number : 21254

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

GLAXO GRP LTD

PEGS Boston Summit

Not Confirmed

GLAXO GRP LTD

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Brand Name : ADVAIR HFA

Dosage Form : AEROSOL, METERED;INHALATION

Dosage Strength : 0.115MG/INH;EQ 0.021MG BASE/INH

Approval Date : 2006-06-08

Application Number : 21254

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

GLAXO GRP LTD

PEGS Boston Summit

Not Confirmed

GLAXO GRP LTD

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Brand Name : ADVAIR HFA

Dosage Form : AEROSOL, METERED;INHALATION

Dosage Strength : 0.23MG/INH;EQ 0.021MG BASE/INH

Approval Date : 2006-06-08

Application Number : 21254

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

HIKMA

PEGS Boston Summit

Not Confirmed

HIKMA

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Brand Name : FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE

Dosage Form : POWDER;INHALATION

Dosage Strength : 0.1MG/INH;EQ 0.05MG BASE/INH

Approval Date : 2020-12-17

Application Number : 203433

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

HIKMA

PEGS Boston Summit

Not Confirmed

HIKMA

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Brand Name : FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE

Dosage Form : POWDER;INHALATION

Dosage Strength : 0.25MG/INH;EQ 0.05MG BASE/INH

Approval Date : 2020-12-17

Application Number : 203433

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.